EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Boesenbergia rotunda extract–based mucoadhesive mouth gargle for chemoradiation-induced oral mucositis: A prospective randomized controlled study

Phitjira Sanguanboonyaphong, Anyamanee Lapmag, Warisada Silaon, Praneet Opanasopit, Woraanong Thiramontre, Suphatcha Khiewvarn, Kanokporn Chamalerk, Worranan Rangsimawong iD

Supportive Care in Cancer · 2026-10 · 34 (10)

DOI: 10.1007/s00520-026-11282-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 03.10.2026. Verfasst von Phitjira Sanguanboonyaphong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Department of Pharmacy Practices, Ubon Ratchathani University, Ubon Ratchathani, 34190, Thailand. Hauptthemen laut MEDLINE: Stomatitis, Plant Extracts, Zingiberaceae, Chemoradiotherapy. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chemotherapy-associated oral mucositis (OM) is a prevalent and debilitating complication in patients undergoing cancer treatment, lacking effective preventive and therapeutic options. Boesenbergia rotunda (BR), a traditional medicinal plant, exhibits potent anti-inflammatory and antimicrobial activities. The objective of this study was to evaluate a BR extract-based mouth gargle for the management of concurrent chemoradiotherapy (CCRT)-induced OM. METHODS: BR extract was evaluated for cytotoxicity and anti-inflammatory activity. The mucoadhesive mouth gargle was characterized by antimicrobial activity, salivary release, and mucosal deposition. Clinical evaluation was performed in patients with head and neck cancer receiving CCRT in a prospective randomized controlled trial conducted between September 2024 and November 2025. The primary outcome of the clinical phase was to compare the incidence of OM at 6 weeks. RESULTS: BR extract was non-cytotoxic at concentrations below 1 µg/mL and significantly suppressed nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells. The formulation demonstrated antimicrobial activity, rapid release within 2 min, and effective mucosal deposition. Fifty-six patients were enrolled, with 73.98% adherence. The incidence of overall OM was significantly lower in the BR extract group than in the control group (30.4% vs. 41.1%, p = 0.04). Lip swelling at week 3 occurred less frequently in the BR group than in the non-intervention group (1.8% vs. 14.3%, p = 0.03), while other adverse events were comparable between groups. CONCLUSION: The BR extract-based mucoadhesive mouth gargle is biocompatible, exhibits anti-inflammatory and antimicrobial activities, and achieves effective mucosal delivery. These findings indicate its potential as a therapeutic strategy for managing CCRT-induced OM. CLINICAL TRIAL NUMBER: Not applicable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StomatitisPlant ExtractsZingiberaceaeChemoradiotherapyMouthwashesHumansProspective StudiesFemaleMaleAnimalsAnti-Inflammatory AgentsMiddle AgedMiceHead and Neck NeoplasmsAgedRAW 264.7 CellsAdult

Stichwörter der Autor:innen

Boesenbergia rotundaAnti-inflammatoryAntimicrobialConcurrent chemoradiotherapyMucoadhesive mouth gargleOral mucositis

Substanzen

Plant ExtractsAnti-Inflammatory AgentsMouthwashes

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Department of Pharmacy Practices, Ubon Ratchathani University, Ubon Ratchathani, 34190, Thailand.
  • Department of Industrial Pharmacy, College of Pharmacy, Rangsit University, Pathum Thani, 12000, Thailand.
  • Faculty of Pharmacy, Department of Industrial Pharmacy, Silpakorn University, Nakhon Pathom, 73000, Thailand.
  • Department of Radiotherapy, Ubon Ratchathani Cancer Hospital, Ubon Ratchathani, 34000, Thailand.
  • Department of Pharmacy, Ubon Ratchathani Cancer Hospital, Ubon Ratchathani, 34000, Thailand.
  • Innovation in Drug and Extract of Agriculture Research Center, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, 34190, Thailand. worranan.r@ubu.ac.th.

ORCID-Profile: Worranan Rangsimawong

Zitieren

APA

Sanguanboonyaphong, P., Lapmag, A., Silaon, W., Opanasopit, P., Thiramontre, W., Khiewvarn, S., Chamalerk, K., & Rangsimawong, W. (2026). Boesenbergia rotunda extract–based mucoadhesive mouth gargle for chemoradiation-induced oral mucositis: A prospective randomized controlled study. Supportive Care in Cancer, 34(10). https://doi.org/10.1007/s00520-026-11282-w

Vancouver

Sanguanboonyaphong P, Lapmag A, Silaon W, Opanasopit P, Thiramontre W, Khiewvarn S, et al. Boesenbergia rotunda extract–based mucoadhesive mouth gargle for chemoradiation-induced oral mucositis: A prospective randomized controlled study. Supportive Care in Cancer. 2026;34(10). doi:10.1007/s00520-026-11282-w

BibTeX
@article{Sanguanboonyaphong2026,
  author = {Sanguanboonyaphong, Phitjira and Lapmag, Anyamanee and Silaon, Warisada and Opanasopit, Praneet and Thiramontre, Woraanong and Khiewvarn, Suphatcha and Chamalerk, Kanokporn and Rangsimawong, Worranan},
  title = {Boesenbergia rotunda extract–based mucoadhesive mouth gargle for chemoradiation-induced oral mucositis: A prospective randomized controlled study},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {10},
  doi = {10.1007/s00520-026-11282-w}
}
Kostenlos starten →